Prostate cancer-associated SPOP mutations lead to genomic instability through disruption of the SPOP–HIPK2 axis. Issue 12 (16th June 2021)

• Record Type: Journal Article
• Authors: Jin, Xiaofeng; Qing, Shi; Li, Qian; Zhuang, Hui; Shen, Liliang; Li, Jinhui; Qi, Honggang; Lin, Ting; Lin, Zihan; Wang, Jian; Cao, Xinyi; Yang, Jianye; Ma, Qi; Cong, Linghua; Xi, Yang; Fang, Shuai; Meng, Xiaodan; Gong, Zhaohui; Ye, Meng; Wang, Shuyun; Wang, Chenji; Gao, Kun
• Is Part Of: Nucleic acids research. Volume 49:Issue 12(2021)
• Page Start: 6788
• Page End: 6803
• Publication Date: 2021-06-16
• Subjects: Nucleic acids -- Periodicals; Molecular biology -- Periodicals; 572.805
• DOI: 10.1093/nar/gkab489
• Languages: English
• ISSNs: 0305-1048

Abstract

Abstract: Speckle-type Poz protein (SPOP), an E3 ubiquitin ligase adaptor, is the most frequently mutated gene in prostate cancer. The SPOP-mutated subtype of prostate cancer shows high genomic instability, but the underlying mechanisms causing this phenotype are still largely unknown. Here, we report that upon DNA damage, SPOP is phosphorylated at Ser119 by the ATM serine/threonine kinase, which potentiates the binding of SPOP to homeodomain-interacting protein kinase 2 (HIPK2), resulting in a nondegradative ubiquitination of HIPK2. This modification subsequently increases the phosphorylation activity of HIPK2 toward HP1γ, and then promotes the dissociation of HP1γ from trimethylated (Lys9) histone H3 (H3K9me3) to initiate DNA damage repair. Moreover, the effect of SPOP on the HIPK2-HP1γ axis is abrogated by prostate cancer-associated SPOP mutations. Our findings provide new insights into the molecular mechanism of SPOP mutations-driven genomic instability in prostate cancer.